Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Freeman

Showing results (181-190 of 191) with videos related to

Pageof 20
Sort By:
Cancer Research|August 30, 2018
Emerin Deregulation Links Nuclear Shape Instability to Metastatic PotentialMariana Reis-Sobreiro, Jie-Fu Chen, Tatiana Novitskaya, et al.
Oncotarget|April 11, 2015
Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesiclesValentina R Minciacchi, Sungyong You, Cristiana Spinelli, et al.
American Journal of Clinical and Experimental Urology|September 20, 2021
Loss of CDCP1 triggers FAK activation in detached prostate cancer cellsSara G Pollan, Pai-Chi Teng, Yu Jen Jan, et al.
The Journal of Pathology. Clinical Research|October 28, 2016
Quantitative imaging for development of companion diagnostics to drugs targeting HGF/METFangjin Huang, Zhaoxuan Ma, Sara Pollan, et al.
Nature Medicine|November 28, 2018
ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axisMirja Rotinen, Sungyong You, Julie Yang, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
Extracellular Vesicles heterogeneity through the lens of multiomicsTaylon F Silva, Elizabeth Hutchins, Wenyan Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 10, 2020
Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate CancerShivanshu Awasthi, Anders Berglund, Julieta Abraham-Miranda, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate CancerChen Qian, Qian Yang, Mirja Rotinen, et al.
Nucleic Acids Research|June 27, 2024
ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancerChen Qian, Qian Yang, Mirja Rotinen, et al.
Cell Reports. Medicine|June 7, 2025
Extracellular vesicle heterogeneity through the lens of multiomicsTaylon F Silva, Elizabeth Hutchins, Wenyan Zhao, et al.
Pageof 20

Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
Cancer Research|August 30, 2018
Emerin Deregulation Links Nuclear Shape Instability to Metastatic PotentialMariana Reis-Sobreiro, Jie-Fu Chen, Tatiana Novitskaya, et al.
Oncotarget|April 11, 2015
Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesiclesValentina R Minciacchi, Sungyong You, Cristiana Spinelli, et al.
American Journal of Clinical and Experimental Urology|September 20, 2021
Loss of CDCP1 triggers FAK activation in detached prostate cancer cellsSara G Pollan, Pai-Chi Teng, Yu Jen Jan, et al.
The Journal of Pathology. Clinical Research|October 28, 2016
Quantitative imaging for development of companion diagnostics to drugs targeting HGF/METFangjin Huang, Zhaoxuan Ma, Sara Pollan, et al.
Nature Medicine|November 28, 2018
ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axisMirja Rotinen, Sungyong You, Julie Yang, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
Extracellular Vesicles heterogeneity through the lens of multiomicsTaylon F Silva, Elizabeth Hutchins, Wenyan Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 10, 2020
Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate CancerShivanshu Awasthi, Anders Berglund, Julieta Abraham-Miranda, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate CancerChen Qian, Qian Yang, Mirja Rotinen, et al.
Nucleic Acids Research|June 27, 2024
ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancerChen Qian, Qian Yang, Mirja Rotinen, et al.
Cell Reports. Medicine|June 7, 2025
Extracellular vesicle heterogeneity through the lens of multiomicsTaylon F Silva, Elizabeth Hutchins, Wenyan Zhao, et al.
Pageof 20